Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation.

Wahl SM, Hunt DA, Wong HL, Dougherty S, McCartney-Francis N, Wahl LM, Ellingsworth L, Schmidt JA, Hall G, Roberts AB, et al.

J Immunol. 1988 May 1;140(9):3026-32.

PMID:
3129508
3.

Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression.

Ruegemer JJ, Ho SN, Augustine JA, Schlager JW, Bell MP, McKean DJ, Abraham RT.

J Immunol. 1990 Mar 1;144(5):1767-76.

PMID:
2407783
4.

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.

Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynck R, Sporn MB, Fauci AS.

J Exp Med. 1986 May 1;163(5):1037-50.

5.

Transforming growth factors beta slow down cell-cycle progression in a murine interleukin-2 dependent T-cell line.

Stoeck M, Miescher S, MacDonald HR, Von Fliedner V.

J Cell Physiol. 1989 Oct;141(1):65-73.

PMID:
2789227
6.

Transforming growth factor-beta s are equipotent growth inhibitors of interleukin-1-induced thymocyte proliferation.

Ellingsworth LR, Nakayama D, Segarini P, Dasch J, Carrillo P, Waegell W.

Cell Immunol. 1988 Jun;114(1):41-54.

PMID:
2897247
8.

Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes.

Kehrl JH, Roberts AB, Wakefield LM, Jakowlew S, Sporn MB, Fauci AS.

J Immunol. 1986 Dec 15;137(12):3855-60.

PMID:
2878044
9.

Effect of transforming growth factor-beta on early and late activation events in human T cells.

Ahuja SS, Paliogianni F, Yamada H, Balow JE, Boumpas DT.

J Immunol. 1993 Apr 15;150(8 Pt 1):3109-18.

PMID:
8468460
10.

TGF-beta inhibits the in vitro induction of lymphokine-activated killing activity.

Grimm EA, Crump WL 3rd, Durett A, Hester JP, Lagoo-Deenadalayan S, Owen-Schaub LB.

Cancer Immunol Immunother. 1988;27(1):53-8.

PMID:
3260821
11.

Transforming growth factor beta from multiple myeloma cells inhibits proliferation and IL-2 responsiveness in T lymphocytes.

Cook G, Campbell JD, Carr CE, Boyd KS, Franklin IM.

J Leukoc Biol. 1999 Dec;66(6):981-8.

13.

Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action.

Dubois CM, Ruscetti FW, Palaszynski EW, Falk LA, Oppenheim JJ, Keller JR.

J Exp Med. 1990 Sep 1;172(3):737-44.

14.
16.

Transforming growth factor-beta inhibits human antigen-specific CD4+ T cell proliferation without modulating the cytokine response.

Tiemessen MM, Kunzmann S, Schmidt-Weber CB, Garssen J, Bruijnzeel-Koomen CA, Knol EF, van Hoffen E.

Int Immunol. 2003 Dec;15(12):1495-504.

17.

Transforming growth factor-beta inhibits human T-cell proliferation through multiple targets.

Fox FE, Capocasale RJ, Ford HC, Lamb RJ, Moore JS, Nowell PC.

Lymphokine Cytokine Res. 1992 Dec;11(6):299-305.

PMID:
1477183
18.

Inhibitory cytokine circuits involving transforming growth factor-beta, interferon-gamma, and interleukin-2 in human monocyte activation.

Espinoza-Delgado I, Bosco MC, Musso T, Mood K, Ruscetti FW, Longo DL, Varesio L.

Blood. 1994 Jun 1;83(11):3332-8.

19.

Down-regulation of murine fibrosarcoma transforming growth factor-beta 1 expression by interleukin 7.

Dubinett SM, Huang M, Dhanani S, Economou JS, Wang J, Lee P, Sharma S, Dougherty GJ, McBride WH.

J Natl Cancer Inst. 1995 Apr 19;87(8):593-7.

PMID:
7752257
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk